ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 121 filers reported holding ANAPTYSBIO INC in Q4 2019. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $282,000 | -49.1% | 10,890 | -57.6% | 0.10% | -50.0% |
| Q1 2021 | $554,000 | -76.7% | 25,690 | -76.7% | 0.19% | -72.3% |
| Q4 2020 | $2,375,000 | +35.5% | 110,448 | -7.1% | 0.69% | +24.4% |
| Q3 2020 | $1,753,000 | -57.5% | 118,858 | -35.7% | 0.56% | -50.3% |
| Q2 2020 | $4,129,000 | -34.2% | 184,846 | -58.4% | 1.12% | -44.3% |
| Q1 2020 | $6,272,000 | -12.4% | 443,877 | +0.8% | 2.02% | -17.4% |
| Q4 2019 | $7,157,000 | – | 440,409 | – | 2.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |